To begin to elucidate this potential pro-tumorigenic role, we determined the gene and protein expression of RCN1 in several commercially available parental cell lines, single cell variant sub-populations, stably transfected and patient-derived primary and recurrent glioblastoma cell lines. The gene discussed is RCN1; the disease is glioblastoma.